REDHILL BIOPHARMA LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2018-12-11: Form 6-K; Period of report 2018-12-11; Description FORM 6-K; Document f6k_121118.htm.
- 2018-12-10: Form 6-K; Period of report 2018-12-10; Description FORM 6-K; Document f6k_121018.htm.
- 2018-12-06: Form 6-K; Period of report 2018-12-06; Description FORM 6-K; Document f6k_120618.htm.
- 2018-12-04: Form 6-K; Period of report 2018-12-04; Description FORM 6-K; Document f6k_120418.htm.